60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)

$0.031 -0.0057 (-15.5313%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 50

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) News Sources

60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue

01-07-2026

yahoo.com

60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases

08-07-2026

yahoo.com

60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026

29-07-2026

yahoo.com

60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules

30-07-2026

yahoo.com

Merck KGaA (MKKGY) Misses Q2 Earnings Estimates

06-08-2026

yahoo.com

Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates

11-08-2026

yahoo.com

60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results

14-08-2026

yahoo.com

60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website

15-04-2026

yahoo.com

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results

15-05-2026

yahoo.com

60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement

11-06-2026

yahoo.com

60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) Sentiment Trend

0 25 50 75 100 53 75 53 56 2 2 61 66 61 67 01-07-2026 08-07-2026 29-07-2026 30-07-2026 06-08-2026 11-08-2026 14-08-2026 15-04-2026 15-05-2026 11-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) FAQs

toggle

What is the current price of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)?

The current price of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) is $0.031.


toggle

60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) absolute price change since previous trading day?

The absolute price change of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) since the previous trading day is $-0.0057.


toggle

60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) percentage price change since previous trading day?

The percentage price change of 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) since the previous trading day is -15.5313%.


toggle

What is the most recent average sentiment score for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)?

The most recent average sentiment score for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) is 50 out of 100.


toggle

What is the most recent average sentiment for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)?

The most recent sentiment for 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ) is .


SEC-8K** Filing Available For 60 DEGREES PHARMA INC-28 (SXTPW:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.